{{Drugbox
| verifiedrevid = 470610046
| IUPAC_name = (''RS'')-2-(5-benzoyl-2-thienyl)propanoic acid
| image = Tiaprofenic acid.svg
| width = 200
| chirality = [[Racemic mixture]]
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CONS|tiaprofenic_acid}}
| pregnancy_category = C
| legal_UK = POM<!-- POM so must be UK -->
| routes_of_administration = oral
<!--Pharmacokinetic data-->
| bioavailability = 90%
| metabolism = 10% hepatic
| elimination_half-life = 1.5-2.5h
| excretion = 50-80% urine
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 33005-95-7
| ATC_prefix = M01
| ATC_suffix = AE11
| PubChem = 5468
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01600
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5269
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1LS1T6R34C
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01325
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 32221
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 365795
<!--Chemical data-->
| C=14 | H=12 | O=3 | S=1
| molecular_weight = 260.309
| smiles = O=C(c1sc(cc1)C(C(=O)O)C)c2ccccc2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H12O3S/c1-9(14(16)17)11-7-8-12(18-11)13(15)10-5-3-2-4-6-10/h2-9H,1H3,(H,16,17)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = GUHPRPJDBZHYCJ-UHFFFAOYSA-N
| synonyms = <small>5-Benzoyl-α-methyl-2-thiopheneacetic acid</small>
}}

'''Tiaprofenic acid''' is a [[nonsteroidal anti-inflammatory drug]] (NSAID) of the arylpropionic acid (profen) class, used to treat pain, especially [[Arthritis|arthritic]] pain. The typical adult dose is 300&nbsp;mg twice daily. It is not recommended in children.

It is sparingly metabolised in the [[liver]] to two inactive metabolites. Most of the drug is eliminated unchanged in the [[urine]]. Renal disease impairs excretion, and it should be used with caution in renal disease.

Long-term use of tiaprofenic acid is associated with severe [[cystitis]], roughly 100 times more commonly than other NSAIDs.<ref>{{cite journal | vauthors = ((Crawford MLA)), Waller PC, Wood SM | title = Severe cystitis associated with tiaprofenic acid | journal = British Journal of Urology | year = 1997 | volume = 79 | issue = 4 | pages = 578–584 | doi = 10.1046/j.1464-410X.1997.00094.x | pmid = 9126086}}</ref> It is contraindicated in patients with cystitis and urinary tract infections.

The earliest reports of clinical use are from France in 1975 <ref>{{cite journal | vauthors = Pons J,  Pasturel A | title =  [How to improve postoperative complications in stomatological, maxillofacial and plastic surgery: evaluation of tiaprofenic acid]. [French] | journal = Revue d Odonto-Stomatologie.  | year = 1975 | volume = 4 | issue = 6 |pages=535–7}}</ref>

It is marketed under the trade names '''Surgam''', '''Surgamyl''' and '''Tiaprofen''', and in [[Generic drug|generic]] formulations. A sustained-release preparation is available. It is an [[isomer]] of [[Suprofen]].

== References ==
{{reflist}}

== External links ==
* Manufacturer Data Sheet [https://web.archive.org/web/20060206225018/http://www.medsafe.govt.nz/Profs/Datasheet/s/Surgamtab.htm]

{{Anti-inflammatory and antirheumatic products}}
{{Prostanoidergics}}

{{DEFAULTSORT:Tiaprofenic Acid}}
[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:Aromatic ketones]]
[[Category:Thiophenes]]


{{musculoskeletal-drug-stub}}